Quercetin
Mechanism, regulatory status, and an honest, tiered evidence map.
What it is
Class: Flavonoid (senolytic combination component)
Also known as: flavonol quercetin
Relationship to senescence: A dietary flavonoid used as the flavonoid partner in the dasatinib+quercetin combination; on its own it is a comparatively weak senolytic and broadens the range of senescent cell types cleared when combined with dasatinib.
Regulatory status
Dietary supplement; not an approved drug and not approved as a senolytic. No established senolytic dose.
Mechanism
Affects Bcl-2-family, PI3K, and SERPINE-related survival nodes; studied almost exclusively in combination, not as a standalone human senolytic. See /dasatinib-quercetin.
Animal lifespan evidence
Animal lifespan evidence: none in this dataset
No single-agent animal lifespan study in this dataset.
This is separate from human lifespan evidence, which is none for every intervention on this site. An animal lifespan result is not a human lifespan result.
Evidence — In vitro / combination verify: verified at review level, not primary source
| Species / population | Cultured senescent cells; human pilots only as part of D+Q. |
| Exposure, route, schedule | Studied in combination with dasatinib; standalone senolytic dosing not established. |
| Comparator / duration | Combination vs single-agent in preclinical work. |
| Endpoint / numeric result | Broadens senescent-cell-type coverage of the combination. |
| What it did NOT establish | No standalone human senolytic evidence; no lifespan data. |
Negative or null findings
- Standalone quercetin has not been shown to clear senescent cells or affect aging outcomes in humans.
The form used in the trials
A product-fact block, not a recommendation. It records the form the trials used and what they administered. SeneSIQ does not rank products, name a best one, suggest a dose, or claim an effect.
| Regulatory status | Dietary supplement; not an approved drug and not approved as a senolytic. No established senolytic dose. |
The search returns several variants. The trials used Quercetin, a dietary flavonol. Human work has studied it only as the flavonoid partner in the dasatinib+quercetin combination, not on its own.
Links marked with an arrow are affiliate links: SeneSIQ may earn a commission if you buy through them, at no extra cost to you. This never affects what is published — see the affiliate disclosure.